219 related articles for article (PubMed ID: 24983629)
1. Additional diagnostic value of MRI in patients with suspicious breast lesions based on ultrasound.
Sarica O; Uluc F
Br J Radiol; 2014 Sep; 87(1041):20140009. PubMed ID: 24983629
[TBL] [Abstract][Full Text] [Related]
2. The value of MRI for downgrading of breast suspicious lesions detected on ultrasound.
Xie Z; Xu W; Zhang H; Li L; An Y; Mao G
BMC Med Imaging; 2023 Jun; 23(1):72. PubMed ID: 37271827
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging of the breast as a problem-solving method: to be or not to be?
Oztekin PS; Kosar PN
Breast J; 2014; 20(6):622-31. PubMed ID: 25200378
[TBL] [Abstract][Full Text] [Related]
4. Elastography Assisted BI-RADS in the Preoperative Breast Magnetic Resonance Imaging 4a Lesions in China.
Tang L; Wang Y; Gong H; Chen M
J Ultrasound Med; 2023 Feb; 42(2):453-461. PubMed ID: 35811402
[TBL] [Abstract][Full Text] [Related]
5. A preliminary study to propose a diagnostic algorithm for PET/CT-detected incidental breast lesions: application of BI-RADS lexicon for US in combination with SUVmax.
Bakhshayeshkaram M; Salehi Y; Abbasi M; Hashemi Beni R; Seifi S; Hassanzad M; Jamaati HR; Aghahosseini F
Eur Radiol; 2019 Oct; 29(10):5507-5516. PubMed ID: 30887201
[TBL] [Abstract][Full Text] [Related]
6. The Kaiser score reliably excludes malignancy in benign contrast-enhancing lesions classified as BI-RADS 4 on breast MRI high-risk screening exams.
Milos RI; Pipan F; Kalovidouri A; Clauser P; Kapetas P; Bernathova M; Helbich TH; Baltzer PAT
Eur Radiol; 2020 Nov; 30(11):6052-6061. PubMed ID: 32504098
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
[TBL] [Abstract][Full Text] [Related]
8. Can second-look ultrasound downgrade MRI-detected lesions? A retrospective study.
Kolta M; Clauser P; Kapetas P; Bernathova M; Pinker K; Helbich TH; Baltzer PAT
Eur J Radiol; 2020 Jun; 127():108976. PubMed ID: 32339982
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic value of a breast MRI score for the prediction of malignancy of breast lesions detected solely with MRI].
Siegmann KC; Moron HU; Baur A; Hahn M; Vogel U; Claussen CD; Bitzer M
Rofo; 2009 Jun; 181(6):556-63. PubMed ID: 19452398
[TBL] [Abstract][Full Text] [Related]
10. Nonpalpable BI-RADS 4 breast lesions: sonographic findings and pathology correlation.
Elverici E; Barça AN; Aktaş H; Özsoy A; Zengin B; Çavuşoğlu M; Araz L
Diagn Interv Radiol; 2015; 21(3):189-94. PubMed ID: 25835079
[TBL] [Abstract][Full Text] [Related]
11. Growing BI-RADS category 3 lesions on follow-up breast ultrasound: malignancy rates and worrisome features.
Ha SM; Chae EY; Cha JH; Shin HJ; Choi WJ; Kim HH
Br J Radiol; 2018 Jul; 91(1087):20170787. PubMed ID: 29658793
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of breast ultrasound in mammography BI-RADS 0 and clinically indeterminate or suspicious of malignancy breast lesions.
Dobrosavljević A; Rakić S; Nikoli B; Raznatović SJ; Dikić SD; Milosević Z; Jurisić A; Skrobić M
Vojnosanit Pregl; 2016 Mar; 73(3):239-45. PubMed ID: 27295907
[TBL] [Abstract][Full Text] [Related]
13. Role of magnetic resonance imaging in probably benign (BI-RADS category 3) microcalcifications of the breast.
Linda A; Zuiani C; Londero V; Di Gaetano E; Dal Col A; Girometti R; Bazzocchi M
Radiol Med; 2014 Jun; 119(6):393-9. PubMed ID: 24297595
[TBL] [Abstract][Full Text] [Related]
14. Probably benign lesions at screening breast US in a population with elevated risk: prevalence and rate of malignancy in the ACRIN 6666 trial.
Barr RG; Zhang Z; Cormack JB; Mendelson EB; Berg WA
Radiology; 2013 Dec; 269(3):701-12. PubMed ID: 23962417
[TBL] [Abstract][Full Text] [Related]
15. Quantitative DWI implemented after DCE-MRI yields increased specificity for BI-RADS 3 and 4 breast lesions.
Dijkstra H; Dorrius MD; Wielema M; Pijnappel RM; Oudkerk M; Sijens PE
J Magn Reson Imaging; 2016 Dec; 44(6):1642-1649. PubMed ID: 27273694
[TBL] [Abstract][Full Text] [Related]
16. MRI in the Assessment of BI-RADS® 4 lesions.
Leithner D; Wengert G; Helbich T; Morris E; Pinker K
Top Magn Reson Imaging; 2017 Oct; 26(5):191-199. PubMed ID: 28961568
[TBL] [Abstract][Full Text] [Related]
17. Role of BI-RADS Ultrasound Subcategories 4A to 4C in Predicting Breast Cancer.
Spinelli Varella MA; Teixeira da Cruz J; Rauber A; Varella IS; Fleck JF; Moreira LF
Clin Breast Cancer; 2018 Aug; 18(4):e507-e511. PubMed ID: 29066139
[TBL] [Abstract][Full Text] [Related]
18. Real-time MRI navigated US: role in diagnosis and guided biopsy of incidental breast lesions and axillary lymph nodes detected on breast MRI but not on second look US.
Pons EP; Azcón FM; Casas MC; Meca SM; Espona JLG
Eur J Radiol; 2014 Jun; 83(6):942-950. PubMed ID: 24725672
[TBL] [Abstract][Full Text] [Related]
19. US and MRI in the evaluation of mammographic BI-RADS 4 and 5 microcalcifications.
Hrkac Pustahija A; Ivanac G; Brkljacic B
Diagn Interv Radiol; 2018 Jul; 24(4):187-194. PubMed ID: 30091708
[TBL] [Abstract][Full Text] [Related]
20. Is a one-year follow-up an efficient method for better management of MRI BI-RADS(®) 3 lesions?
Boisserie-Lacroix M; Ziadé C; Hurtevent-Labrot G; Ferron S; Brouste V; Lippa N
Breast; 2016 Jun; 27():1-7. PubMed ID: 27212693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
